Eurofins Consumer Product Testing acquires Modern Testing Services as part of its strategic expansion in consumer products industry

Eurofins Consumer Product Testing (CPT) is pleased to announce the acquisition of Modern Testing Services (MTS), a full-service safety and quality services provider for the consumer product industry, as an integral component of its worldwide strategic expansion plan.

Eurofins CPT, comprised of a global network of over 80 laboratories with a strong footprint in Europe, is an innovative and fast-growing services provider for consumer product industry. MTS, having been firmly rooted in the industry for over 15 years, holds a high reputation and strong customer portfolios, especially in North America. MTS’ expertise spans across a wide range of products, including textiles & apparel, toys, hardgoods, food contact, health & beauty, electrical & electronics and chemicals. Customers from both companies will enjoy an enhanced synergy from expanded global services network and experts.

The acquisition of MTS will further accelerate the pursuit of the Eurofins CPT goal of becoming a top leader in the testing, inspection and certification (TIC) industry for the consumer products industry.

About Modern Testing Services

Modern Testing Services (MTS) was founded in 2006 as an independent consumer products quality assurance company specializing in product testing, inspection, and QA/QC services.

Today, MTS sets its footprint in more than 19 worldwide locations comprised of some of the most technically strong and innovative minds in the industry.

The mission of MTS is to deliver accurate, efficient, and cost-effective technical services with the highest level of integrity to ensure the quality and safety of consumer products.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. Eurofins is the global leader in food, environment, and pharmaceutical product testing. It is also one of the market leaders in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing.

With over 55,000 staff across a network of more than 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.